34 related articles for article (PubMed ID: 14744943)
1. Pharmacokinetics of fluoxetine in rhesus macaques following multiple routes of administration.
Sawyer EK; Howell LL
Pharmacology; 2011; 88(1-2):44-9. PubMed ID: 21757974
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective study of fluoxetine and norfluoxetine across the blood-brain barrier mediated by organic cation transporter 1/3 in rats using an enantioselective UPLC-MS/MS method.
An H; Fang J; Wang M; Lin H; Sun Y; Hu B; He Z; Ge Z; Wei Y
Chirality; 2023 Dec; 35(12):983-992. PubMed ID: 37464916
[TBL] [Abstract][Full Text] [Related]
3. Pronounced Inter-Individual Variation in Plasma Cortisol Response to Fluoxetine Hydrochloride in the Pig.
Marsh LE; Terry R; Whittaker AL; Hiendleder S; Ralph CR
Animals (Basel); 2020 Mar; 10(3):. PubMed ID: 32197320
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine Inhibits Canonical Wnt Signaling to Impair Embryoid Body Morphogenesis: Potential Teratogenic Mechanisms of a Commonly Used Antidepressant.
Warkus ELL; Marikawa Y
Toxicol Sci; 2018 Oct; 165(2):372-388. PubMed ID: 29893963
[TBL] [Abstract][Full Text] [Related]
5. In vitro modulation of estrogen receptor activity by norfluoxetine.
Lupu D; Pop A; Cherfan J; Kiss B; Loghin F
Clujul Med; 2015; 88(3):386-90. PubMed ID: 26609274
[TBL] [Abstract][Full Text] [Related]
6. Placental transfer of antidepressant medications: implications for postnatal adaptation syndrome.
Ewing G; Tatarchuk Y; Appleby D; Schwartz N; Kim D
Clin Pharmacokinet; 2015 Apr; 54(4):359-70. PubMed ID: 25711391
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of fluoxetine in pregnant baboons (Papio spp.).
Shoulson RL; Stark RL; Garland M
J Am Assoc Lab Anim Sci; 2014 Nov; 53(6):708-16. PubMed ID: 25650979
[TBL] [Abstract][Full Text] [Related]
8. A novel chiral GC/MS method for the analysis of fluoxetine and norfluoxetine enantiomers in biological fluids.
Mifsud J; Sghendo LJ
J Pharm Bioallied Sci; 2012 Jul; 4(3):236-45. PubMed ID: 22923967
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding.
Kim J; Riggs KW; Misri S; Kent N; Oberlander TF; Grunau RE; Fitzgerald C; Rurak DW
Br J Clin Pharmacol; 2006 Feb; 61(2):155-63. PubMed ID: 16433870
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine during pregnancy: impact on fetal development.
Morrison JL; Riggs KW; Rurak DW
Reprod Fertil Dev; 2005; 17(6):641-50. PubMed ID: 16263070
[TBL] [Abstract][Full Text] [Related]
11. New approaches for drug and kinetic analysis in the maternal-fetal unit.
Tonn GR; Doroudian A; Gordon JG; Rurak DW; Riggs KW; Abbott FS; Axelson JE
NIDA Res Monogr; 1995; 154():175-202. PubMed ID: 8606744
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective pharmacokinetics of fluoxetine and norfluoxetine enantiomers in pregnant sheep.
Kim J; Riggs KW; Rurak DW
Drug Metab Dispos; 2004 Feb; 32(2):212-21. PubMed ID: 14744943
[TBL] [Abstract][Full Text] [Related]
13. An
Chow TW; Nguyen TA; Riggs KW; Rurak DW
Xenobiotica; 2019 Nov; 49(11):1360-1372. PubMed ID: 30587071
[TBL] [Abstract][Full Text] [Related]
14. The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine.
Fjordside L; Jeppesen U; Eap CB; Powell K; Baumann P; Brøsen K
Pharmacogenetics; 1999 Feb; 9(1):55-60. PubMed ID: 10208643
[TBL] [Abstract][Full Text] [Related]
15. Population PK modelling and simulation based on fluoxetine and norfluoxetine concentrations in milk: a milk concentration-based prediction model.
Tanoshima R; Bournissen FG; Tanigawara Y; Kristensen JH; Taddio A; Ilett KF; Begg EJ; Wallach I; Ito S
Br J Clin Pharmacol; 2014 Oct; 78(4):918-28. PubMed ID: 24773313
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
